loading...| Preferred Name | aflibercept | |
| Synonyms |
AVE-0005 AVE 005 AVE-005 AVE005 VEGF Trap - regeneron VEGF-Trap ZIV-aflibercept AVE0005 eylea Zaltrap VEGF Trap-Eye AVE 0005 |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C533178 |
|
| altLabel |
AVE-0005 AVE 005 AVE-005 AVE005 VEGF Trap - regeneron VEGF-Trap ZIV-aflibercept AVE0005 eylea Zaltrap VEGF Trap-Eye AVE 0005 |
|
| cui |
C3485624 C3248025 C2606270 C2606271 C1134659 C3485619 |
|
| HM |
D040262 D011993 |
|
| Inverse of RB |
15C2VL427D 0 |
|
| isa | ||
| LT |
TRD |
|
| Mapped to | ||
| MDA |
20081127 |
|
| MeSH Frequency |
1869 |
|
| MMR |
20210112 |
|
| notation |
C533178 |
|
| PA |
D020533 |
|
| prefLabel |
aflibercept |
|
| SC |
1 |
|
| Scope Statement |
has antiangiogenic activity; consists of the second and third Ig domains of VEGFR1 and VEGFR2, respectively, fusion to the Fc region of IgG1; putative antineoplastic agent that binds all VEGF-A isoforms; possible medicine for eye disorders |
|
| SRC |
Drugs R D 2008;9(4):261-9 |
|
| TERMUI |
T837958 T730806 T730808 T730810 T730807 T780563 T837957 T730812 T730811 T730738 T730809 T820728 T730813 |
|
| TH |
NLM (2008) FDA SRS (2017) NLM (2012) USAN (2008) INN (19XX) NLM (2013) NLM (2010) |
|
| tui |
T109 T116 T129 T123 T121 |